Recent Patents on Inflammation & Allergy Drug Discovery
Title:Patent Selections:
Volume: 9 Issue: 2
Export Options
About this article
Cite this article as:
Patent Selections:, Recent Patents on Inflammation & Allergy Drug Discovery 2015; 9 (2) . https://dx.doi.org/10.2174/1872213X0902160211151418
DOI https://dx.doi.org/10.2174/1872213X0902160211151418 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
30
Related Articles
-
ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy
Current Pharmaceutical Design Recent Advances and Approaches in Targeting Apoptosis Signaling Pathways for Anti-Cancer Therapeutics
Current Cancer Therapy Reviews The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Current Pharmaceutical Design Computational Studies on Translocator Protein (TSPO) and its Ligands
Current Topics in Medicinal Chemistry IL-13 and its Signal Pathway: Promising Targets in the Development of a Therapeutic Agent for Bronchial Asthma
Current Signal Transduction Therapy Better Targeting Melanoma: Options Beyond Surgery and Conventional Chemotherapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Aceruloplasminemia
Current Drug Targets Pannexin Channels: The Emerging Therapeutic Targets
Current Drug Targets Molecular Targets of Omega-3 Fatty Acids for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases
Current Drug Targets Peptide Therapeutics in Neurodegenerative Disorders
Current Medicinal Chemistry Resveratrol and Analogues: A Review of Antioxidant Activity and Applications to Human Health
Recent Patents on Food, Nutrition & Agriculture Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and <i>in vitro</i> Studies
Current Cancer Drug Targets Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents
Current Drug Targets Systems Cytogenomics: Are We Ready Yet?
Current Genomics Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Hypersensitivity to Antineoplastic Agents
Current Pharmaceutical Design Recent Software Developments and Applications in Functional Imaging
Current Pharmaceutical Biotechnology Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy
Current Molecular Pharmacology Small Peptide and Protein-based Molecular Probes for Imaging Neurological Diseases
Current Protein & Peptide Science